News
AstraZeneca AZN-Q -1.14% on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback